Skip to main content

Table 3 The relationship between GSTM1 genotypes and microangiopathic complications in diabetic patients

From: Evaluation of glutathione S-transferase polymorphism in Iranian patients with type 2 diabetic microangiopathy

Groups/variables

Null

Wild

P value

DM without DR vs. DM with DR

13/97 (13.4)

7/109 (6.42)

84/97 (86.6)

102/109 (93.58)

0.073

DM without DN vs. DM with DN

9/149 (6.04)

11/57 (19.3)

140/149 (93.96)

46/57 (80.7)

0.006

DM without DNp vs. DM with DNp

9/104 (8.65)

11/102 (10.78)

95/104 (91.35)

91/102 (89.22)

0.389

DM without DNa vs. DM with DNa

13/146 (8.9)

7/60 (11.67)

133/146 (91.1)

53/60 (88.33)

0.354

DM without microangiopathy vs. DM with microangiopathy

4/72 (5.56)

16/134 (11.94)

68/72 (94.44)

118/134 (88.06)

0.107

Control vs. DM

15/114 (13.16)

20/206 (9.7)

99/114 (86.84)

186/206 (90.3)

0.222

  1. DM diabetes mellitus; DR diabetic retinopathy; DN diabetic nephropathy; DNp peripheral diabetic neuropathy; DNa autonomic diabetic neuropathy
  2. The data are expressed as in n (%)